Filing Flows › Evolus (EOLS) › Q2 2026 › vs Q2 2025
Evolus (EOLS) Q2 2026 vs Q2 2025 (year over year)
Evolus's revenue rose $14.7M (+21%) from $69.4M in Q2 2025 to $84.1M in Q2 2026. The biggest changes: Product revenue, net +$14.7M (+21%); Service revenue +$46K (+7%).
Evolus, Q2 2026: revenue $84.1M (+21% year over year), operating margin -5.4%, net loss $8.1M, operating cash flow −$3.6M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product revenue, net | $83.3M | $68.7M | $14.7M | +21% |
| Service revenue | $734K | $688K | $46K | +7% |
| Revenue | $84.1M | $69.4M | $14.7M | +21% |
| Income tax benefit | $154K | −$53K | $207K | — |
| Net loss | $8.1M | $17.1M | −$9.1M | -53% |
| Costs & expenses | $92.3M | $86.5M | $5.8M | +7% |
| Operating costs | $88.6M | $79.6M | $9.0M | +11% |
| Interest & other, net | $3.7M | $6.9M | −$3.2M | -47% |
| Cost of revenue | $26.9M | $24.1M | $2.8M | +12% |
| Operating cash sources | $11.5M | $31.0M | −$19.5M | -63% |
| Depreciation & amortization | $2.3M | $1.7M | $598K | +34% |
| Share-based compensation | $5.6M | $4.5M | $1.1M | +25% |
| Cash used in operations | $3.6M | $24.8M | −$21.2M | -86% |
| Net loss absorbed | $8.1M | $17.1M | −$9.1M | -53% |
| Working capital & other | $3.5M | $13.9M | −$10.4M | -75% |
Questions
How much did Evolus's revenue grow year over year in Q2 2026?
Evolus's revenue rose $14.7M (+21%) from $69.4M in Q2 2025 to $84.1M in Q2 2026.
What drove Evolus's revenue change in Q2 2026?
Product revenue, net +$14.7M (+21%); Service revenue +$46K (+7%).